Sarepta Therapeutics, Inc. (SRPT)
About Sarepta Therapeutics, Inc.
Sarepta Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, gene therapies, and other genetic medicines for rare diseases, particularly neuromuscular disorders. The company has developed approved treatments for Duchenne muscular dystrophy, including EXONDYS 51, VYONDYS 53, AMONDYS 45, and ELEVIDYS, and is advancing additional therapeutic candidates for neuromuscular and other rare diseases. The company operates in one segment: discovering, developing, manufacturing, and delivering therapies to patients with rare diseases.
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
Financial summary
- Revenue FY2025
- $1.9B
- Net income
- -$713.4M
- Total assets
- $3.3B
- Market cap
- $1.7B
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $1.7B
- Shares outstanding
- 93.4M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jun 4, 1997
Sarepta Therapeutics, Inc. (SRPT) Stock Price
- Reported a net loss of $713.4M in FY2025.
- Trading 27% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
Peers & competitors
No reviews yet. Be the first to review Sarepta Therapeutics, Inc..
Write a review
News about Sarepta Therapeutics, Inc.
News & sentiment via Polygon.io
Sarepta Therapeutics, Inc.: frequently asked questions
Is Sarepta Therapeutics, Inc. an American company?
Sarepta Therapeutics, Inc. is a US-based company headquartered in Cambridge, Massachusetts, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Sarepta Therapeutics, Inc. headquartered?
Sarepta Therapeutics, Inc. is headquartered in Cambridge, Massachusetts, United States.
Is Sarepta Therapeutics, Inc. publicly traded?
Yes — Sarepta Therapeutics, Inc. is a publicly traded company. Its stock trades under the ticker symbol SRPT on the NASDAQ.
What does Sarepta Therapeutics, Inc. do?
Sarepta Therapeutics, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
When was Sarepta Therapeutics, Inc. founded?
Sarepta Therapeutics, Inc. was founded in 1980.
